In brain ischemia, levels of CASP3 mRNA and protein were increased, and its activity was significantly reversed by a CASP3 inhibitor, preventing the hydrolyzation of poly(ADP-ribose) polymerase. This evidence concerns the gene CASP3 and brain ischemia.